FONAR Celebrates the 50th Anniversary of the Origination of the MRI
19 Setembro 2019 - 12:00PM
FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™,
celebrated a special anniversary on September 17, 2019: It was 50
years ago that Raymond V. Damadian, M.D., founder and chairman of
FONAR Corporation, first thought about developing a device using
magnetic resonance to scan the human body to detect cancer.
On September 17, 1969, Dr. Damadian sent a
letter to Dr. George Mirick of the Health Research Council of the
City of New York requesting financial support for equipment to
follow up his promising line of research.
In that letter, Dr. Damadian wrote, “I will make
every effort myself and through collaborators, to establish that
all tumors can be recognized by their potassium relaxation times or
H2O-proton spectra and proceed with the development of
instrumentation and probes that can be used to scan the human body
externally for early signs of malignancy. Detection of
internal tumors during the earliest stages of their genesis should
bring us very close to the total eradication of this disease,”
marking the origination of the MRI scanner.
It was during the following year, on June 18,
1970, that Dr. Damadian performed the first experiments whereby he
discovered the distinctly elongated time-lapsed signal marking
differences between normal and cancerous tissue, as well as
differences among various normal organs themselves that make the
MRI image. “That was my ‘Eureka!’ moment,” said Dr.
Damadian. The results of his experiments were subsequently
published in the journal Science on March 19, 1971.
Today thousands upon thousands of MRI scanners
are scanning millions of patients every year all over the world.
According to December 4, 2003 issue of The Economist, “About 22,000
MRI machines around the world were used in 60 million examinations
in 2002 last year.”
Perhaps Professor Donlin Long, M.D., former
Chairman of Neurosurgery, Johns Hopkins University, says it best:
MRI is “The Single Most Important Diagnostic Discovery in the
History of All of Medicine.” Professor Long made this statement on
November 10, 2018, when Dr. Damadian was awarded the Excellence in
Medicine Medal of Honor from the Chiari & Syringomyelia
Foundation at Brooks’s in London, England. He was joined by
Fraser Henderson, M.D., a neurosurgeon and member of the steering
committee for the Chiari & Syringomyelia Foundation, who said,
“Raymond Damadian revolutionized medicine with the discovery and
development of MRI.”
Dr. Damadian’s September 17, 1969 letter to Dr.
George Mirick may be viewed online at
http://fonar.com/nobel.htm#1969_letter. The letter may also
be viewed in the three attachments to this release.
About FONAR
FONAR, the Inventor of MR Scanning™, is
located in Melville, NY, was incorporated in 1978, and is the
first, oldest and most experienced MRI company in the industry.
FONAR introduced the world’s first commercial MRI in 1980, and went
public in 1981. FONAR’s signature product is the FONAR UPRIGHT®
Multi-Position™ MRI (also known as the STAND-UP® MRI), the only
whole-body MRI that performs Position™ Imaging (pMRI™) and scans
patients in numerous weight-bearing positions, i.e. standing,
sitting, in flexion and extension, as well as the conventional
lie-down position. The FONAR UPRIGHT® MRI often detects
patient problems that other MRI scanners cannot because they are
lie-down and ”weightless” only scanners. The patient-friendly
UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate.
As a FONAR customer states, “If the patient is claustrophobic in
this scanner, they’ll be claustrophobic in my parking lot.”
Approximately 85% of patients are scanned sitting while watching
TV.
FONAR has new works-in-progress technology
for visualizing and quantifying the cerebral hydraulics of the
central nervous system, the flow of cerebrospinal fluid (CSF),
which circulates throughout the brain and vertebral column at the
rate of 32 quarts per day. This imaging and quantifying of the
dynamics of this vital life-sustaining physiology of the body’s
neurologic system has been made possible first by FONAR’s
introduction of the MRI and now by this latest works-in-progress
method for quantifying CSF in all the normal positions of the body,
particularly in its upright flow against gravity. Patients with
whiplash or other neck injuries are among those who will benefit
from this new understanding.
FONAR’s substantial list of patents includes
recent patents for its technology enabling full weight-bearing MRI
imaging of all the gravity sensitive regions of the human anatomy,
especially the brain, extremities and spine. It includes its newest
technology for measuring the Upright cerebral hydraulics of the
central nervous system. FONAR’s UPRIGHT® Multi-Position™ MRI
is the only scanner licensed under these patents.
UPRIGHT® and STAND-UP® are registered trademarks
and The Inventor of MR Scanning™, Full Range of Motion™,
Multi-Position™, Upright Radiology™, The Proof is in the Picture™,
True Flow™, pMRI™, Spondylography™, Dynamic™, Spondylometry™, CSP™,
and Landscape™, are trademarks of FONAR Corporation.
This release may include forward-looking
statements from the company that may or may not materialize.
Additional information on factors that could potentially affect the
company's financial results may be found in the company's filings
with the Securities and Exchange Commission.
|
|
The Inventor of MR Scanning™ |
Contact: Daniel Culver |
|
An ISO 9001 Company |
Director of Communications |
|
Melville, New York 11747 |
E-mail: investor@fonar.com |
|
Phone: (631) 694-2929 |
www.fonar.com |
|
Fax: (631) 390-1772 |
|
|
|
Attachments accompanying this announcement are
available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a3e97373-a458-44bf-b543-be30ce3fa6b3
https://www.globenewswire.com/NewsRoom/AttachmentNg/e3912bb2-f35b-4a86-b53c-64333fde26e0
https://www.globenewswire.com/NewsRoom/AttachmentNg/0e85a6bc-9c18-467d-b99e-3e9e7097d0ec
Fonar (NASDAQ:FONR)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Fonar (NASDAQ:FONR)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025